Aytu BioPharma Inc. (AYTU)

Business: Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally.

IPO Date: 01-Feb-2017

Chairman & CEO: Mr. Joshua R. Disbrow

Chief Financial Officer: Mr. Mark K. Oki CPA

Listing: NASDAQ: AYTU

Country: United States

Headquarters: Englewood, CO

Website: https://aytubio.com

Market cap: $20.03 Mln

Revenue (TTM): $92.70 Mln

Earnings (TTM): $-111.47 Mln

Cash: $27.61 Mln

Total Debt: $21.26 Mln

Insider's Holding: 4.82%

Liquidity: Low

52 Week range: $0.45 - 5.38

Shares outstanding: 38,574,900

10 Years Aggregate:

• CFO: $-120.81 Mln
• EBITDA: $-132.01 Mln
• Net Profit: $-173.34 Mln